PharmaShots | Incisive News in 3 Shots

Subscribe Now

Ascentage Pharma

Ascentage Pharma Entered into Clinical Collaboration with AstraZeneca for Lisaftoclax + Acalabrutinib in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Ascentage Pharma Entered into Clinical Collaboration with AstraZeneca for Lisaftoclax + Acalabrutinib in Chronic Lymphocytic Leuke...

October 17, 2023

Ascentage Pharma to Present P-II Study Results of Lisaftoclax (APG-2575) for Chronic Lymphocytic Leukemia at ASH 2022

Ascentage Pharma to Present P-II Study Results of Lisaftoclax (APG-2575) for Chronic Lymphocytic Leukemia at ASH 2022

November 4, 2022

Ascentage Pharma's Alrizomadlin (APG-115) Receives the US FDA’s Rare Pediatric Disease Designation for the Treatment of Neuroblastoma

Ascentage Pharma's Alrizomadlin (APG-115) Receives the US FDA’s Rare Pediatric Disease Designation for the Treatment of Neuroblast...

March 22, 2022

Ascentage Pharma Entered into a Clinical Collaboration with Clover to Evaluate APG-1387 + SCB-313 for the Treatment of Peritoneal Carcinomatosis

Ascentage Pharma Entered into a Clinical Collaboration with Clover to Evaluate APG-1387 + SCB-313 for the Treatment of Peritoneal...

December 10, 2021

PharmaShots Weekly Snapshots (July 06 - 10, 2020)

PharmaShots Weekly Snapshots (July 06 - 10, 2020)

July 13, 2020

PharmaShots Weekly Snapshot (November 04-08, 2019)

PharmaShots Weekly Snapshot (November 04-08, 2019)

November 11, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us